Navigation Menu
COVID

COVID-19 UPDATES

News and Stories for Sites and Sponsors

Top Story

The rise of the Remote Research Coordinator role

As the industry continues to lift enrollment holds and initiate new trials, site workload will increase. To alleviate some of the administrative burden and increase site staff while adhering to social distancing requirements, sites should consider hiring remote clinical research coordinators.

Latest Stories
Most Popular

Leaders of Jounce Therapeutics and Alector say sites and sponsors should continue to increase use of remote technology

In WCG’s tenth installment of their COVID webinar series, industry experts discuss updates to clinical trial operations and challenges in emerging biopharmaceutical companies with focused pipelines.

eConsent can benefit sites during and after COVID

Sites and sponsors have rapidly adjusted trials practices to include virtual tools. eConsent is one such tool and has quickly become more widely accepted. CRIO has gathered information on how your site can implement eConsent and compiled a list of its benefits.

Sites give Sponsors and CROs feedback that they should have study-specific contingency plans in place for another outbreak

Medidata has been monitoring the impact of the pandemic on clinical development by surveying investigator sites. Their latest report discusses impact of lockdowns, sites’ biggest concerns and suggestions to Sponsors and CROs.

Business continuity plan for clinical research: why eSource matters during COVID-19

A former research site manager discusses all the ways her CRIO system allowed her site to operate during the COVID-19 crisis with minimal productivity decline. As your site ramps up, consider going electronic now as a way to ensure business continuity.

More news
Access Your Data Anywhere.

Your study doesn't stop just because you're at home instead of at the clinic.

Request a Demo

or call us at 617-302-9845

Download
Clinical research site SOPs (124k DOC)

Courtesy of a clinical research site

Webinar
Advarra Expert Discusses Latest FDA Guidance on COVID Tuesday, March 24, 2020 | 12:00AM EDT